| 09:15 - 09:50 AM | Keynote: Virus infection to cancer: The interferon paradox | David Brooks, PhD
University of Toronto, Canada |
| 09:55 - 10:10 AM | Peripheral and tumor immune signatures predict response to immunotherapy in advanced HER2-negative breast cancer | Sabrina Dhooge
CIBICI, National University of Córdoba, Argentina |
| 10:15 - 10:30 AM | MATH-only proteins (MOPs): Emerging immunoregulators in inflammation-related diseases | Mohadeseh Ahmadvand
York University - MHRC, UHN – Krembil Research Institute, Canada |
| 10:35 - 10:50 AM | Loss of MYSM1 deubiquitinase catalytic activity protects against MYC-driven lymphoma | Anastasia Nijnik, PhD
McGill University, Canada |
| 10:55 - 11:10 AM | Bone marrow dormant tumor cells maintain reactive memory CD8 T cells | Fernando Flores-Guzman, PhD
University of Colorado, U.S.A. |
| 11:15 - 11:30 AM | FAM72A potentiates APOBEC3B-driven cytidine deamination and mutagenic repair to promote colorectal tumorigenesis | Yan Gao, PhD
University of Toronto, Canada |
| 11:35 - 11:50 AM | Regulatory T cells guard against thermogenic dysfunction in brown adipose tissue | Nathan Zammit, PhD
Harvard Medical School, GentiBio, U.S.A. |
| 11:55 - 12:30 PM | Keynote: Designing a universal vaccine through integrated organ immunity | Bali Pulendran, PhD
Institute for Immunity, Transplantation & Infection, Stanford University, U.S.A. |
| 12:30 - 12:45 PM | HotDoc: Safeguarding cancer care during crises: Lessons from the Institute of Cancer and Crisis | Christos Tsagkaris
University of Zurich, University Children's Hospital, Switzerland |